It is actually not possible to find out whether these gatherings are related on to the use of PDE5 inhibitors, into the patient's underlying vascular hazard factors or anatomical defects, to a combination of these aspects, or to other components [see WARNINGS AND Safety measures and Affected person INFORMATION].The drug could keep on Doing the job